Evidence-Based Lifestyle Prescription Program: Pilot Study (HeSP)

September 27, 2017 updated by: Robert Petrella, Western University, Canada

Canadian Diabetes Strategy Research Project - HealtheSteps™: Exercise and Healthy Eating Prescriptions to Reduce the Risk of Diabetes in Rural and Remote Communities: A Pilot Pragmatic Randomized Controlled Trial (Project 3).

The HealtheSteps™ (HeS) Program is an evidence-based, community-focused, lifestyle prescription (Rx) program, supported by in-person coaching and innovative health technologies. The program improves the health of Canadians and reduces their risk for chronic disease by tackling three major risk factors that are shared across a number of chronic diseases: physical inactivity, sedentary behaviour and poor diet. Each HeS participant receives an individualized healthy living Rx for exercise, physical activity (step counts) and healthy eating, supported by coaching and technology tools to promote long-term health behaviour change. For this study, the investigators will undertake a 6-month pilot pragmatic randomized controlled trial (RCT), conducted within 5 clinic settings in Southwestern Ontario. The primary aim is to conduct an outcome evaluation to determine the effectiveness of the HeS program in helping at-risk individuals increase physical activity levels, improve eating habits, and improve other health behaviours and health indicators.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The HealtheSteps™ (HeS) program was developed to improve the health of Canadians and reduce their risk for chronic disease (CD) and brings together emerging evidence from the areas of physical activity, nutrition, behaviour change, health technologies, and knowledge transfer, and moves knowledge into practice. HeS is an evidence-based, viable, and scalable healthy lifestyle solution to tackle the epidemic of CD in Canada. HeS goes beyond traditional health promotion messaging to give individuals a specific plan of action to improve their health and provides community settings with hands-on training, and resources from study knowledge brokers (KBs) to facilitate program uptake and sustainability. The investigators suggest that a widely available HeS program has the potential to impact the lives of Canadians at-risk for and living with CD; shift practice patterns within Family Health Teams (FHTs), Community Health Centres (CHCs) and clinics; reduce health care costs associated with CD; and inform policy decisions about health resource allocation and human resource planning. A scaled-up HeS program will offer at-risk Canadians an opportunity to actively participate in an evidence-based, community-focused, affordable (no cost to participant), healthy lifestyle program supported by point-of-care coaching and innovative electronic Health (eHealth) technologies.

This study will use a two-arm, pilot pragmatic randomized controlled trial (RCT) design. It will take place within 5 clinic settings in Southwestern Ontario. Following assessment of eligibility and baseline measurements, participants will be individually randomized (1:1; stratified by clinical setting) to either the intervention group (receiving the HeS program) or to the comparison group (usual care wait-list control). The comparison group will be offered to start the HeS program after a 6 month delay. All participants (both intervention and comparison groups) will receive publicly available healthy eating and physical activity materials at baseline. Measurements will be taken at baseline and 6 months in both groups; additional follow-up measurements will be taken in the intervention group only at 12 months and again at 18 months (from baseline). Groups will be compared at 6-months in order to examine effectiveness of the HeS program; further, follow-up to 12 and 18 months will be used to look at maintenance of any changes in the intervention group only.

Study Type

Interventional

Enrollment (Actual)

118

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • London, Ontario, Canada, N6G 1J1
        • SJHC Family Medical Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • One or more self-reported or measured risk factors for chronic disease including: a) objectively-measured body-mass index of greater than or equal to 25 kg/m2; b) less than 150 minutes of exercise per week; c) greater than 3 hours of sitting per day; d) less than 8 fruit and vegetable servings per day; e) diagnosis of metabolic syndrome or type 2 diabetes
  • Clear Physical Activity Readiness Questionnaire (PAR-Q) (i.e., either by answering "No" to all questions or receiving clearance from a healthcare provider)

Exclusion Criteria:

  • Unable to comprehend letter of information and consent documentation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HealtheSteps Program
6 month evidence-based lifestyle Rx program: receive lifestyle Rx's for exercise, physical activity (step counts) and healthy eating and set goals around Rx's (in person sessions at set time points during 6-month period); take part in self-directed healthy living activities to achieve Rx's (Months 0-6); access to a suite of health technology support options for additional support and coaching (Months 0-6).
6-month evidence-based lifestyle Rx program: At set time points over the 6-month period, participants have in-person visits with a HeS coach at the clinic setting. At each in-person session, the participant receives an individualized Rx for exercise, physical activity (step count) and healthy eating. The HeS Coach and participant then engage in a coaching/goal setting conversation to set detailed plans and goals to achieve their prescriptions. Participants independently choose which activities they will take part in to achieve their lifestyle Rx's and goals. In between in-person sessions, the participants have access to a suite of free-of-charge health technology support tools to: a) track their exercise, physical activity, and healthy eating; and b) receive virtual coaching and support.
No Intervention: Usual-care wait-list control
No active intervention (usual care).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average steps per day
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
Measured over 7-day monitoring period using pedometers (Yamax Digiwalker SW200 model)
6 months (plus 12 and 18 months in the intervention group only)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total physical activity (metabolic equivalent (MET)-minutes/week)
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
From the International Physical Activity Questionnaire - Short Version
6 months (plus 12 and 18 months in the intervention group only)
Time spent in sedentary activity (minutes/day)
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
From the International Physical Activity Questionnaire - Short Version
6 months (plus 12 and 18 months in the intervention group only)
Eating habits: Total healthful eating score
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
Measured by Starting the conversation questionnaire
6 months (plus 12 and 18 months in the intervention group only)
Eating habits: Fruit and vegetable consumption
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
Measured by the modified Dietary Instrument for Nutrition Education questionnaire
6 months (plus 12 and 18 months in the intervention group only)
Eating habits: Fatty food score
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
Measured by the modified Dietary Instrument for Nutrition Education questionnaire
6 months (plus 12 and 18 months in the intervention group only)
Eating habits: sugary food consumption
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
Measured by the modified Dietary Instrument for Nutrition Education questionnaire
6 months (plus 12 and 18 months in the intervention group only)
Health-related quality of life: self-rated health
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
Visual Analogue Scale score measured using questionnaire known as EQ-5D-3L
6 months (plus 12 and 18 months in the intervention group only)
Resting systolic blood pressure
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
Measured using automated blood pressure monitor
6 months (plus 12 and 18 months in the intervention group only)
Resting diastolic blood pressure
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
Measured using automated blood pressure monitor
6 months (plus 12 and 18 months in the intervention group only)
Weight loss (absolute and percentage)
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
Measured using digital weight scale
6 months (plus 12 and 18 months in the intervention group only)
Waist circumference
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
Measured using tape measure
6 months (plus 12 and 18 months in the intervention group only)
Body mass index
Time Frame: 6 months (plus 12 and 18 months in the intervention group only)
Calculated from height (stadiometer) and weight (digital weight scale) measurements
6 months (plus 12 and 18 months in the intervention group only)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2015

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

March 1, 2017

Study Registration Dates

First Submitted

April 6, 2015

First Submitted That Met QC Criteria

April 6, 2015

First Posted (Estimate)

April 9, 2015

Study Record Updates

Last Update Posted (Actual)

September 28, 2017

Last Update Submitted That Met QC Criteria

September 27, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight

Clinical Trials on HealtheSteps Program

3
Subscribe